|
Volumn 43, Issue 3, 2002, Pages 203-206
|
Treatment of canine atopic dermatitis with zafirlukast, a leukotriene-receptor antagonist: A single-blinded, placebo-controlled study
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIHISTAMINIC AGENT;
ANTIPRURITIC AGENT;
GLUCOCORTICOID;
IMMUNOMODULATING AGENT;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
MONTELUKAST;
NONSTEROID ANTIINFLAMMATORY AGENT;
PLACEBO;
ZAFIRLUKAST;
ZILEUTON;
ARTICLE;
ATOPIC DERMATITIS;
CHEMOTHERAPY INDUCED EMESIS;
CONTROLLED STUDY;
DOG DISEASE;
DRUG EFFICACY;
DRUG EXCRETION;
DRUG METABOLISM;
DRUG URINE LEVEL;
FEMALE;
MALE;
NONHUMAN;
PRURITUS;
SINGLE BLIND PROCEDURE;
ADMINISTRATION, ORAL;
ANIMALS;
CROSS-OVER STUDIES;
DERMATITIS, ATOPIC;
DOG DISEASES;
DOGS;
FEMALE;
LEUKOTRIENE ANTAGONISTS;
MALE;
SINGLE-BLIND METHOD;
TOSYL COMPOUNDS;
TREATMENT OUTCOME;
CANIS FAMILIARIS;
EMESIS;
|
EID: 0036233898
PISSN: 00085286
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (11)
|
References (27)
|